Sign In
Buy OCGN
$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
Is There Any Hope for Ocugen?
06:00am, Wednesday, 09'th Mar 2022
The company has hit several roadblocks along the coronavirus vaccine path.
Ocugen Fell Today: Is It a Buy Now?
09:01pm, Tuesday, 08'th Mar 2022 The Motley Fool
The company needs some good news to turn things around.
Why Ocugen Stock Is Falling Today
04:51pm, Tuesday, 08'th Mar 2022 The Motley Fool
Last week's sell-off is continuing into this week.
Why Ocugen Stock Is Falling Today
11:51am, Tuesday, 08'th Mar 2022
Last week's sell-off is continuing into this week.
Ocugen Is Two Strikes in With a Third in the Books
10:42am, Tuesday, 08'th Mar 2022
Ocugen has tried repeatedly to bring drugs to market, first as Histogenics and later under its current name. The post Ocugen Is Two Strikes in With a Third in the Books appeared first on InvestorPlace
5 of the Fastest-Growing Stocks On the Planet
10:06am, Tuesday, 08'th Mar 2022 The Motley Fool
Wall Street is calling for five-year sales growth ranging from 273% to infinity for these innovative stocks.
5 of the Fastest-Growing Stocks On the Planet
05:06am, Tuesday, 08'th Mar 2022
Wall Street is calling for five-year sales growth ranging from 273% to infinity for these innovative stocks.
Ocugen (OCGN) Down 23% With FDA Denial of COVID Vaccine EUA
10:27pm, Monday, 07'th Mar 2022 Zacks Investment Research
The FDA turns down an emergency use authorization request from Ocugen (OCGN) to use its COVID-19 vaccine Covaxin in pediatric population. Stock depreciates.
Ocugen (OCGN) Down 23% With FDA Denial of COVID Vaccine EUA
06:46pm, Monday, 07'th Mar 2022
The FDA turns down an emergency use authorization request from Ocugen (OCGN) to use its COVID-19 vaccine Covaxin in pediatric population. Stock depreciates.
Bharat Biotech''s Covaxin gets FDA nod for clinical trials in adults in US
02:52pm, Monday, 07'th Mar 2022 Livemint
Bharat Biotech and its US partner Ocugen expressed their commitment towards bringing Covaxin to the US and Canada for all age groups, the company said
Why Ocugen Stock Is Crashing Today
04:42pm, Friday, 04'th Mar 2022 The Motley Fool
The U.S. FDA refused to grant Emergency Use Authorization for COVID-19 vaccine Covaxin in immunizing kids.
Why Is Ocugen (OCGN) Stock Down Today?
04:15pm, Friday, 04'th Mar 2022 InvestorPlace
Shares of OCGN stock are in the red after the company''s Covaxin Covid-19 vaccine was declined EUA by the FDA. Here''s what you should know.
Thinking about buying stock in VEON, E-Home Household Service, Tonix Pharmaceuticals, American Airlines, or Ocugen?
04:15pm, Friday, 04'th Mar 2022 Benzinga
NEW YORK , March 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VEON, EJH, TNXP, AAL, and OCGN. … Full story available on Benzinga.com
Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA''s Covaxin Rejection
04:12pm, Friday, 04'th Mar 2022 InvestorPlace
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.
Covid-19: US FDA declines to issue EUA for Covaxin for use in individuals aged 2 to 18 years.
03:14pm, Friday, 04'th Mar 2022 The Hindu BusinessLine
Ocugen — Bharat Biotech’s US and Canada partner — will continue working with FDA to evaluate regulatory pathway for the pediatric use of Covaxin
